Marshall Wace’s Enfusion, Inc. ENFN Stock Holding History

Marshall Wace’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-43,417	Closed	-$484K	–	3311
2025 Q1	$484K	Sell	43,417 -67,441	-61%	-$745K	﹤0.01%	2088
2024 Q4	$1.14M	Buy	+110,858	New	+$1.07M	﹤0.01%	1671
2023 Q3	–	Sell	-34,221	Closed	-$384K	–	2777
2023 Q2	$384K	Sell	34,221 -121,442	-78%	-$1.08M	﹤0.01%	2070
2023 Q1	$1.63M	Buy	155,663 +113,153	+266%	+$1.25M	﹤0.01%	1565
2022 Q4	$411K	Buy	42,510 +15,993	+60%	+$180K	﹤0.01%	2447
2022 Q3	$327K	Buy	+26,517	New	+$323K	﹤0.01%	2914
2022 Q1	–	Sell	-36,763	Closed	-$769K	–	4147
2021 Q4	$769K	Buy	+36,763	New	+$743K	﹤0.01%	2605

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Marshall Wace's ENFN Position: Q2 2025 in Review

Marshall Wace sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 43,417 shares — an estimated $484K sold.

Marshall Wace first reported a position in ENFN in Q4 2021 and held it in 7 quarters. The position peaked at $1.63M in Q1 2023. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Marshall Wace reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Marshall Wace sold 43,417 Enfusion, Inc. shares in Q2 2025, an estimated $484K.
Marshall Wace first reported a position in Enfusion, Inc. in Q4 2021 and held it in 7 quarters.
Marshall Wace's Enfusion, Inc. position peaked at $1.63M in Q1 2023.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.